Can Moderna Make mRNA Work in Flu?
12 August 2026.
Moderna’s flu approval tests whether mRNA can deliver commercial scale
vaccines
When Vaccine Policy Becomes Market Risk
22 July 2026.
Policy, platforms and manufacturing are reshaping global vaccine market opportunities
The Next Phase of Vaccine Growth
27 May 2026.
Vaccines are shifting from prevention into platforms, oncology and manufacturing-led growth
Vaccine Sales Market Report 2026-2036: 6.3% CAGR
22 May 2026.
The global Vaccine Sales market is projected to grow at a CAGR of 6.3% by 2036
mRNA Vaccines Market Report 2026-2036
14 May 2026.
mRNA vaccine platforms expand beyond prevention into oncology and immune-mediated diseases
mRNA Cancer Vaccine Market Report 2026-2036: 27.1% CAGR
21 April 2026.
The global mRNA Cancer Vaccine market is projected to grow at a CAGR of 27.1% by 2036
The Vaccine Contract Manufacturing Advantage.
12 January 2026.
The global Vaccine Contract Manufacturing market is projected to grow at a CAGR of 10.9% by 2036
mRNA Revolution: the Future of Cancer Care
24 December 2025.
mRNA cancer vaccines advance toward oncology reality, driven by personalisation, combination therapies, scalable manufacturing.
mRNA Contract Manufacturing: The Emergent White Space for CDMOs
10 September 2025.
Scaling fragile mRNA demands advanced CDMO integration, automated quality control, and −80°C infrastructure maturity.
